Monthly Archives: July 2012

CHOICE submission to ACCC – Medicines Australia Code of Conduct 17th Edition

The ACCC has called for submissions about Medicines Australia latest Code of Conduct. A submission by CHOICE (The Australian Consumers Association) with which I was involved can be downloaded here.

Posted in Pharmaceutical Promotion | Tagged , | Leave a comment

Medicines Australia Code of Conduct 17th Edition

I have talked about my concerns with this latest Code revision in a short video that can be found here.

Posted in Pharmaceutical Promotion | Tagged , | Leave a comment

Undoit threatens to sue Harvey

Undoit threatens to sue Harvey http://www.pharmainfocus.com.au/news.asp?newsid=5612 Posted 16 July 2012 The maker of controversial diet pill Undoit has threatened to sue activist Ken Harvey for defamation over remarks he made about the product on ABC radio. The company’s solicitors have … Continue reading

Posted in Complementary medicine, Pharmaceutical Promotion | Tagged , , , , | Leave a comment

GSK cops $3 bn fine for largest health care fraud in US; 17th Edition of Medicines Australia Code released

Not surprisingly, these two news items led to a discussion on Australian television (and elsewhere) of whether the promotional activities of the pharmaceutical industry should be governed by self-regulatory industry codes of conduct or by co-regulation involving the government and … Continue reading

Posted in Pharmaceutical Promotion | Tagged , , , , , , , | Leave a comment

Two complaints upheld

The determinations by the Therapeutic Goods Advertising Complaint Resolution Panel (TGACRP) and Medicines Australia Code of Conduct Committee respectively can be viewed here: Undoit determination Pfizer Lipitor determination

Posted in Complementary medicine, Pharmaceutical Promotion | Tagged , , , | Leave a comment